Let me try and clarify what I was trying to say...
Long-term, and assuming that GTCB can avoid the LFB takeover next summer, I believe GTCB will become a valuable investment worth probably in excess of $2 per share. Short-term however, the financial problems of GTCB are real and the LFB takeover is a real possibility. However, even in that "worse case scenario" of an LFB takeover, I think the takeover price would be of the order of $0.7 per share rather than the $0.31 per share that we all fear. In conclusion, I consider GTCB a very good buy at below $0.5...
Of course the above is all IMO and worse scenarios could be envisioned such as LFB letting GTCB sink on its own weight and taking it over for much less than I suggest. However, given the recent FDA approval and validation of the technology, I doubt that will be the case...
Market Data 
Markets 
AI
